Vectorious articles

The first clinical data of an implantable heart sensor with remote measurement capacity was presented at the prestigious ESC Heart Failure 2022 Late-Breaking Science event

Israel-based Vectorious Medical Technologies announced the positive results from the VECTOR-HF I study of its V-LAP novel wireless system.

The first-in-man clinical study was intended to check the safety, ease of use, and accuracy of the V-LAP system, which is implanted permanently in the left atria

TEL AVIV, Israel–(BUSINESS WIRE)–Vectorious Medical Technologies Ltd., today announced that it has enrolled the first six patients in t

The “world’s first in-heart microcomputer” and an endovascular aortic repair (EVAR) suture-delivery catheter were recognized Saturday as the best innovations of CRT 2021 Virtual.

The judges chose the V-LAP implantable microcomputer (Vectorious Medical Technologies Ltd.), presented by Tal Hasin, MD, of Shaare Zedek Medical Center, Jerusalem. CRT audience members voted for Vesteck Suture-Tight (Vesteck Inc.), a catheter that delivers nitinol sutures to secure

Vectorious Medical Technologies today announced that the FDA has granted breakthrough device designation for the company’s left atrial pressure (LAP) monitoring device.

The V-LAP system is the first digital, wireless, battery-free device that can communicate from deep within the body using high-resolution waveform morphology, according to the Tel Aviv-based startup. Because the pressure of the heart&rsqu